Use of 5-[[4-[2-[5-acetylpyridin-2-yl]ethoxy]benzyl]-1,3-thiazolidine-2,4-dione and salts thereof
BR112020024917A2
METHOD OF ADMINISTERING A THERAPEUTICALLY EFFECTIVE AMOUNT OF 5 - [[4- [2- [5- (1-HYDROXYETHIL) PIRIDIN-2-IL] ETOXI] PHENYL] METHIL] -1,3-THIAZOLIDINE-2,4-DIONA
EP3801515A1
5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione and its salts for use in the treatment of mitochondrial diseases
US2019337922A1
Heteroaryl compounds and their use
CA3047700A1
Isoquinoline compounds, methods for their preparation, and therapeutic uses thereof in conditions associated with the alteration of the activity of beta galactosidase
CA3046744A1
Process for preparing 5-[[4-[2-[5-(1-hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]methyl]-2,4-thiazolidinedione and salts thereof
